APA

Alderson H. V., Ritchie J. P., Middleton R., Larsson A., Larsson T. E. & Kalra P. A. (20170227). FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5. : Nephrology (Carlton, Vic.).

Chicago

Alderson Helen V, Ritchie James P, Middleton Rachel, Larsson Anders, Larsson Tobias E and Kalra Philip A. 20170227. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5. : Nephrology (Carlton, Vic.).

Harvard

Alderson H. V., Ritchie J. P., Middleton R., Larsson A., Larsson T. E. and Kalra P. A. (20170227). FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5. : Nephrology (Carlton, Vic.).

MLA

Alderson Helen V, Ritchie James P, Middleton Rachel, Larsson Anders, Larsson Tobias E and Kalra Philip A. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5. : Nephrology (Carlton, Vic.). 20170227.